Diflorasone Diacetate

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Sep 14, 1977	FloroneNDA 17741 · New molecular entity	Pfizer	20	Discontinued
Mar 1, 1978	Psorcon ENDA 17994 · New dosage form	Pfizer	22	Discontinued
Aug 28, 1985	Florone ENDA 19259 · New dosage form	Pfizer	9	Discontinued
Aug 28, 1985	PsorconNDA 19260 · New dosage form	Pfizer	7	Discontinued
Nov 20, 1992	PsorconNDA 20205 · New formulation or manufacturer	Taro Pharms North	2	Discontinued
Mar 30, 1998	Diflorasone DiacetateANDA 75187	Avondale Pharms	3	Discontinued
Apr 27, 1999	Diflorasone DiacetateANDA 75374	Avondale Pharms	5	Marketed
May 14, 1999	Diflorasone DiacetateANDA 75331	Sun Pharma Canada	3	Marketed
Apr 24, 2000	Diflorasone DiacetateANDA 75508	Sun Pharma Canada	4	Marketed
Dec 20, 2002	Diflorasone DiacetateANDA 76263	Ani Pharms	3	Discontinued
Jul 24, 2015	Diflorasone DiacetateANDA 206572	Sciegen Pharms	0	Discontinued
Feb 27, 2017	Diflorasone DiacetateANDA 207440	Rising	0	Marketed
Jun 12, 2018	Diflorasone DiacetateANDA 210753	The J Molner	0	Marketed

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA